Skip to content

Clinical trials

Phase 2 Cystitis, Interstitial trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cystitis, Interstitial Phase: Phase 2 Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20072
20082
20091
20102
20112
20122
20133
20154
20171
20191
20203
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated10
Recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan5
Pfizer3
Urigen3
Corewell Health East2
Vaneltix Pharma, Inc.2
Walter Reed National Military Medical Center2
AbbVie1
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Aquinox Pharmaceuticals (Canada) Inc.1
Duke University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cystitis, Interstitial31
Pelvic Pain4
Urinary Bladder Diseases2
Vulvodynia2
Back Pain1
Chronic Pain1
Communicable Diseases1
Cystitis1
Endometriosis1
Fatigue Syndrome, Chronic1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.